Russell Investments Group, Ltd. Lineage Cell Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$1.12 - $1.61 $7,799 - $11,212	-6,964 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$1.84 - $2.68 $9,972 - $14,525	-5,420 Reduced 43.77%	6,964 $17,000
Q3 2021 Nov 08, 2021	SELL	$2.26 - $2.86 $7,688 - $9,729	-3,402 Reduced 21.55%	12,384 $31,000
Q2 2021 Aug 04, 2021	BUY	$2.17 - $3.0 $34,255 - $47,358	15,786 New	15,786 $44,000
Q3 2020 Nov 09, 2020	SELL	$0.75 - $1.09 $571,372 - $830,394	-761,830 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$0.71 - $1.18 $540,899 - $898,959	761,830 New	761,830 $665,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $95.1M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.